BioSpace News Archive

Drug Development

Maze Therapeutics Initiates Phase 1 First-in-Human Trial Evaluating MZE782 as a Potential Treatment for Chronic Kidney Disease

October 1, 2024
·
3 min read
Press Releases

Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts

October 1, 2024
·
25 min read
Drug Development

Remedy Pharmaceuticals’ Phase 3 Trial in Large Lesion Stroke Patients Demonstrates Statistically Significant Effect at One Year

October 1, 2024
·
3 min read
Press Releases

HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY

October 1, 2024
·
16 min read
Press Releases

New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome

October 1, 2024
·
5 min read
Business

Humanetics to Participate in the Bio Investor Forum in San Francisco

October 1, 2024
·
2 min read
Press Releases

Aspen Neuroscience Announces Expansion of Autologous Cell Therapy Manufacturing in San Diego

October 1, 2024
·
3 min read
Press Releases

Relu Secures FDA 510(k) and CE Marking for Revolutionary Dental Software Relu® Creator

October 1, 2024
·
2 min read
Press Releases

Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device

October 1, 2024
·
4 min read
Press Releases

U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Size to Reach USD 7.46 Bn By 2033

October 1, 2024
·
1 min read